Sarah C Gilbert
Sarah C Gilbert
Professor of Vaccinology, Jenner Institute, Oxford University
Verified email at
TitleCited byYear
Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara
J Schneider, SC Gilbert, TJ Blanchard, T Hanke, KJ Robson, CM Hannan, ...
Nature medicine 4 (4), 397-402, 1998
Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans
H McShane, AA Pathan, CR Sander, SM Keating, SC Gilbert, K Huygen, ...
Nature medicine 10 (11), 1240-1244, 2004
Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans
SJ McConkey, WHH Reece, VS Moorthy, D Webster, S Dunachie, ...
Nature medicine 9 (6), 729-735, 2003
Natural selection of hemi-and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria
C Ruwende, SC Khoo, RW Snow, SNR Yates, D Kwiatkowski, S Gupta, ...
Nature 376 (6537), 246-249, 1995
Upregulation of TGF-β, FOXP3, and CD4+ CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection
M Walther, JE Tongren, L Andrews, D Korbel, E King, H Fletcher, ...
Immunity 23 (3), 287-296, 2005
Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara
DP Webster, S Dunachie, JM Vuola, T Berthoud, S Keating, SM Laidlaw, ...
Proceedings of the National Academy of Sciences 102 (13), 4836-4841, 2005
Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime
T Hanke, TJ Blanchard, J Schneider, CM Hannan, M Becker, SC Gilbert, ...
Vaccine 16 (5), 439-445, 1998
Enhanced immunogenicity of CD4+ T-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis
H McShane, R Brookes, SC Gilbert, AVS Hill
Infection and immunity 69 (2), 681-686, 2001
Association of malaria parasite population structure, HLA, and immunological antagonism
SC Gilbert, M Plebanski, S Gupta, J Morris, M Cox, M Aidoo, ...
Science 279 (5354), 1173-1177, 1998
Potent CD8+ T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA−NP+M1
TK Berthoud, M Hamill, PJ Lillie, L Hwenda, KA Collins, KJ Ewer, A Milicic, ...
Clinical infectious diseases 52 (1), 1-7, 2011
Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis
HM Vordermeier, B Villarreal-Ramos, PJ Cockle, M McAulay, SG Rhodes, ...
Infection and immunity 77 (8), 3364-3373, 2009
Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria
NW Schmidt, RL Podyminogin, NS Butler, VP Badovinac, BJ Tucker, ...
Proceedings of the National Academy of Sciences 105 (37), 14017-14022, 2008
Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
KJ Ewer, GA O’Hara, CJA Duncan, KA Collins, SH Sheehy, ...
Nature communications 4, 2836, 2013
Induction of CD8+ T cells using heterologous prime‐boost immunisation strategies
J Schneider, SC Gilbert, CM Hannan, P Dégano, E Prieur, EG Sheu, ...
Immunological reviews 170 (1), 29-38, 1999
A protein particle vaccine containing multiple malaria epitopes
SC Gilbert, M Plebanski, SJ Harris, CEM Allsopp, R Thomas, GT Layton, ...
Nature biotechnology 15 (12), 1280-1284, 1997
Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime–boost immunisation regimes
SC Gilbert, J Schneider, CM Hannan, JT Hu, M Plebanski, R Sinden, ...
Vaccine 20 (7-8), 1039-1045, 2002
Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+ M1, in Humans
PJ Lillie, TK Berthoud, TJ Powell, T Lambe, C Mullarkey, AJ Spencer, ...
Clinical infectious diseases 55 (1), 19-25, 2012
MVA. 85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques
FAW Verreck, RAW Vervenne, I Kondova, KW van Kralingen, ...
PloS one 4 (4), 2009
Prime-boost vectored malaria vaccines: progress and prospects
AVS Hill, A Reyes-Sandoval, G O’Hara, K Ewer, A Lawrie, A Goodman, ...
Human vaccines 6 (1), 78-83, 2010
Original papers QJM
R Bellamy, C Ruwende, K McAdam, M Thursz, M Sumiya, J Summerfield, ...
QJ Med 91, 13-18, 1998
The system can't perform the operation now. Try again later.
Articles 1–20